Citation: Bb. Yang et al., EFFECTS OF ATORVASTATIN, AN HMG-COA REDUCTASE INHIBITOR, ON HEPATIC OXIDATIVE-METABOLISM OF ANTIPYRINE, Journal of clinical pharmacology, 36(4), 1996, pp. 356-360
Authors:
GIBSON DM
BRON NJ
RICHENS A
HOUNSLOW NJ
SEDMAN AJ
WHITFIELD LR
Citation: Dm. Gibson et al., EFFECT OF AGE AND GENDER ON PHARMACOKINETICS OF ATORVASTATIN IN HUMANS, Journal of clinical pharmacology, 36(3), 1996, pp. 242-246
Authors:
BOPP B
GUSTAVSON L
JOHNSON M
HIGHTOWER B
MULFORD D
CURRY T
SOMMERVILLE KW
CHASSEAUD LF
WOOD SG
FREEDMAN PS
HOUNSLOW NJ
Citation: B. Bopp et al., PHARMACOKINETICS AND METABOLISM OF [C-14] TIAGABINE HCL AFTER ORAL-ADMINISTRATION TO HUMAN-SUBJECTS, Epilepsia, 36, 1995, pp. 158-158